We did the surgery perfectly, yet the patient died anyway… we designed the medical device perfectly, yet the patient died anyway… we followed the regulation perfectly, yet the patient died anyway.
All are iterations on the same theme, i.e., all have the same root cause: answers are only as good as the questions we ask!
Or put another way: what good is designing the right medical device if we are solving the wrong problem?
Is regulatory and quality simply about making sure your design inputs match your user needs, i.e., ticking the boxes? What if your user needs are wrong? Do we need regulation to require us to make sure we are solving the right problems? asking the right questions?
Regulation is all about the interpretation of words and your ability to defend your interpretation.
Using the case study approach, this presentation will cover:
-What is a design input and how do we make sure we have the right ones?
-What's the relationship between design inputs and user needs?
-How do we turn “user inputs” into a viable product and more importantly the right product!
-How do we “translate” user needs to design requirements? Can regs helps?
-How to read between the lines of user feedback, i.e., wants vs. needs?
-How do we sync design requirements and user needs?
-What are the challenges for the future?
Learn more, and watch the presentation, here: https://www.greenlight.guru/webinar/bridging-user-needs-design-requirements
FDA's Case for Quality: What, Why, and How? Changing the Regulatory ParadigmGreenlight Guru
Top-quality medical devices help the FDA better protect and promote public health. And one of the top priorities for FDA's medical devices center is a focus on quality.
The FDA launched the Case for Quality in 2011 following an in-depth review of device quality data and feedback from both FDA and industry stakeholders.
This program allows the FDA to recognize device manufacturers that are capable of consistently producing high-quality devices and continuously improving.
Greenlight Guru is partnering with FDA CDRH to help spread the word and promote the Case for Quality initiative and its benefits to the medical device industry. This is the first of four presentations, learn about the others at greenlight.guru.
Key points in this presentation:
-Learn about CfQ – What it is, why we are doing it, and how we are engaging
-Introduce pilot programs – Provide summary detail on various pilots at CDRH and associated with CfQ
-Regulatory paradigm – How is FDA rethinking the regulatory engagement
Watch this presentation, by Franciso Vicenty, the Case for Quality Manager of the FDA, here: https://www.greenlight.guru/webinar/fda-case-for-quality
5 Predictions for the Medical Device Industry in 2018 (and how you can prepare)Greenlight Guru
What should the medical device industry expect in 2018?
Great question.
From ISO 13485 being revised in 2016, the EU MDR / IVDR being revised in 2017, and the MDSAP program going live in 2017, regulatory changes have been rampant and significant for medical device professionals.
This presentation covers:
- Why you should expect it to be harder for devices to get to market and stay there in the EU
- How to avoid the mad dash to update ISO 13485 certification before the deadline
- Where the latest revision of ISO 14971 is and when to expect the next update
- About Health Canada and their MDSAP deadline
- Why companies are shifting from being compliance-focused to quality-focused
Watch the presentation, commentated by Greenlight Guru's founder Jon Speer, here: https://www.greenlight.guru/webinar/2018-medical-device-industry-predictions
How to Prepare for the New EU In Vitro Diagnostics RegulationsGreenlight Guru
Agreement was reached on the eagerly awaited new EU In Vitro Diagnostic Regulations (IVDR) earlier this year.
The IVDR will significantly change the way IVDs bear the CE mark, and it will include a completely new risk-based classification system.
Now 80% of all IVDs will need to be certified by a notified body under the IVDR where as before, only 20% needed to under the IVD Directive.
The new IVDR is expected to be formally published in late 2016 or early 2017, and there will be a five-year transition period to be compliant.
Many forward thinking IVD companies are already developing their plans for compliance now to gain strategic advantages over their competitors.
This presentation includes:
-Why the European regulations are changing
-What does the new regulation mean for IVD manufactures
-How to classify your IVD using the new risk-based classification system
-How to evaluate your existing clinical evidence to know if new studies will be needed to support your CE mark
-An overview of all the most significant changes brought by the IVDR
-What IVD manufactures can do to start preparing now
Watch the presentation here: https://www.greenlight.guru/webinar/eu-in-vitro-diagnostic-regulations-ivdr
Software as a Medical Device (SaMD) Challenges and Opportunities for 2021 and...Greenlight Guru
The SARS-CoV-2 pandemic drastically changes the landscape of digital health innovation. The FDA authorized emergency use for a variety of SaMD products including but not limited to mental health, clinical decision support and remote monitoring software applications. In addition, FDA recently launched the Digital Health Center of Excellence, provided updates on the pre-certification program, and host a session to convey FDA’s current thinking on AI/ML SaMD validation.
SaMD manufacturers must keep up with the fast-evolving regulatory landscape and optimize their software development practices with a goal to demonstrate conformance to the QMS requirements effectively and efficiently.
This presentation originally aired during the 2021 State of Medical Device Virtual Summit.
FDA's 510(k) Modernization: What if Anything has Changed? Is Changing? Will C...Greenlight Guru
FDA caused quite a stir when it announced transformative changes to modernize its 510(k) program to improve the safety and effectiveness of medical devices.
But as we all know, the more things change, the more they stay the same. If you dive deep into FDA’s statement, you’ll realize that there’s probably not a lot that’s different.
In this session, Michael Drues, Ph.D., President of Vascular Sciences, will share what FDA's 510(k) Modernization means, any evidence that changes are happening, and what medical device manufactures need to know about 510k modernization.
This presentation originally aired during the 2021 State of Medical Device Virtual Summit.
How Design Controls & Risk Management Best Practices Reduce Customer Complain...Greenlight Guru
We all know how much emphasis FDA inspectors and ISO auditors place on your customer complaint and CAPA processes. And rightfully so.
But what if there were things you could do to minimize the struggles and challenges associated with customer complaint and CAPA management?
Good news. You can decrease the number of customer complaints and reduce the volume of issued CAPAs through good product development Design Controls and Risk Management practices.
Specifically this presentation will cover:
-Influence Design Controls has on Customer Complaints
-How Customer Complaints impact your CAPA system
-Best practices for Design Controls
-Best practices for Risk Management
-Risk-based approaches to Customer Complaint and CAPA management
Through practical case studies and industry specific analysis sessions, Medical Device UDIs & Traceability Forum Europe 2015 is geared around strengthening your regulatory infrastructure, maintaining productivity and ensuring ROI from your UDI projects.
View the full agenda here: bit.ly/MedicalDeviceUDI2015Agenda
Alternatively, email enquire@iqpc.co.uk or call +44 (0)207 036 1300 for a copy.
FDA’s Digital Software Pre-Certification ProgramEMMAIntl
The digital health software precertification program is FDA’s strong footstep in leading the way to support the inclusion of the digital world in the US healthcare industry. As part of FDA’s digital health innovation action plan, the pre-cert program was announced in July 2017, and since then has gained tremendous acceptance by the industry...
FDA's Case for Quality: What, Why, and How? Changing the Regulatory ParadigmGreenlight Guru
Top-quality medical devices help the FDA better protect and promote public health. And one of the top priorities for FDA's medical devices center is a focus on quality.
The FDA launched the Case for Quality in 2011 following an in-depth review of device quality data and feedback from both FDA and industry stakeholders.
This program allows the FDA to recognize device manufacturers that are capable of consistently producing high-quality devices and continuously improving.
Greenlight Guru is partnering with FDA CDRH to help spread the word and promote the Case for Quality initiative and its benefits to the medical device industry. This is the first of four presentations, learn about the others at greenlight.guru.
Key points in this presentation:
-Learn about CfQ – What it is, why we are doing it, and how we are engaging
-Introduce pilot programs – Provide summary detail on various pilots at CDRH and associated with CfQ
-Regulatory paradigm – How is FDA rethinking the regulatory engagement
Watch this presentation, by Franciso Vicenty, the Case for Quality Manager of the FDA, here: https://www.greenlight.guru/webinar/fda-case-for-quality
5 Predictions for the Medical Device Industry in 2018 (and how you can prepare)Greenlight Guru
What should the medical device industry expect in 2018?
Great question.
From ISO 13485 being revised in 2016, the EU MDR / IVDR being revised in 2017, and the MDSAP program going live in 2017, regulatory changes have been rampant and significant for medical device professionals.
This presentation covers:
- Why you should expect it to be harder for devices to get to market and stay there in the EU
- How to avoid the mad dash to update ISO 13485 certification before the deadline
- Where the latest revision of ISO 14971 is and when to expect the next update
- About Health Canada and their MDSAP deadline
- Why companies are shifting from being compliance-focused to quality-focused
Watch the presentation, commentated by Greenlight Guru's founder Jon Speer, here: https://www.greenlight.guru/webinar/2018-medical-device-industry-predictions
How to Prepare for the New EU In Vitro Diagnostics RegulationsGreenlight Guru
Agreement was reached on the eagerly awaited new EU In Vitro Diagnostic Regulations (IVDR) earlier this year.
The IVDR will significantly change the way IVDs bear the CE mark, and it will include a completely new risk-based classification system.
Now 80% of all IVDs will need to be certified by a notified body under the IVDR where as before, only 20% needed to under the IVD Directive.
The new IVDR is expected to be formally published in late 2016 or early 2017, and there will be a five-year transition period to be compliant.
Many forward thinking IVD companies are already developing their plans for compliance now to gain strategic advantages over their competitors.
This presentation includes:
-Why the European regulations are changing
-What does the new regulation mean for IVD manufactures
-How to classify your IVD using the new risk-based classification system
-How to evaluate your existing clinical evidence to know if new studies will be needed to support your CE mark
-An overview of all the most significant changes brought by the IVDR
-What IVD manufactures can do to start preparing now
Watch the presentation here: https://www.greenlight.guru/webinar/eu-in-vitro-diagnostic-regulations-ivdr
Software as a Medical Device (SaMD) Challenges and Opportunities for 2021 and...Greenlight Guru
The SARS-CoV-2 pandemic drastically changes the landscape of digital health innovation. The FDA authorized emergency use for a variety of SaMD products including but not limited to mental health, clinical decision support and remote monitoring software applications. In addition, FDA recently launched the Digital Health Center of Excellence, provided updates on the pre-certification program, and host a session to convey FDA’s current thinking on AI/ML SaMD validation.
SaMD manufacturers must keep up with the fast-evolving regulatory landscape and optimize their software development practices with a goal to demonstrate conformance to the QMS requirements effectively and efficiently.
This presentation originally aired during the 2021 State of Medical Device Virtual Summit.
FDA's 510(k) Modernization: What if Anything has Changed? Is Changing? Will C...Greenlight Guru
FDA caused quite a stir when it announced transformative changes to modernize its 510(k) program to improve the safety and effectiveness of medical devices.
But as we all know, the more things change, the more they stay the same. If you dive deep into FDA’s statement, you’ll realize that there’s probably not a lot that’s different.
In this session, Michael Drues, Ph.D., President of Vascular Sciences, will share what FDA's 510(k) Modernization means, any evidence that changes are happening, and what medical device manufactures need to know about 510k modernization.
This presentation originally aired during the 2021 State of Medical Device Virtual Summit.
How Design Controls & Risk Management Best Practices Reduce Customer Complain...Greenlight Guru
We all know how much emphasis FDA inspectors and ISO auditors place on your customer complaint and CAPA processes. And rightfully so.
But what if there were things you could do to minimize the struggles and challenges associated with customer complaint and CAPA management?
Good news. You can decrease the number of customer complaints and reduce the volume of issued CAPAs through good product development Design Controls and Risk Management practices.
Specifically this presentation will cover:
-Influence Design Controls has on Customer Complaints
-How Customer Complaints impact your CAPA system
-Best practices for Design Controls
-Best practices for Risk Management
-Risk-based approaches to Customer Complaint and CAPA management
Through practical case studies and industry specific analysis sessions, Medical Device UDIs & Traceability Forum Europe 2015 is geared around strengthening your regulatory infrastructure, maintaining productivity and ensuring ROI from your UDI projects.
View the full agenda here: bit.ly/MedicalDeviceUDI2015Agenda
Alternatively, email enquire@iqpc.co.uk or call +44 (0)207 036 1300 for a copy.
FDA’s Digital Software Pre-Certification ProgramEMMAIntl
The digital health software precertification program is FDA’s strong footstep in leading the way to support the inclusion of the digital world in the US healthcare industry. As part of FDA’s digital health innovation action plan, the pre-cert program was announced in July 2017, and since then has gained tremendous acceptance by the industry...
ValGenesis Case Study With Scinopharm -Paperless Validation Software Solution ValGenesis
ValGenesis delivered a validated and qualified system in six weeks – the rapid implementation we needed. The system has been stable from the start, with little need for customer support calls, allowing us to focus on training and bringing on new users every week.”
— Steve Johnson, Director, Operations
Injectable Facility
ScinoPharm Taiwan, Ltd.
OSMA: Orthopedic Industry's Top Regulatory Challenges and OpportunitiesApril Bright
The Orthopaedic Surgical Manufacturers Association, a collective voice of orthopedic device companies that influences the decision of worldwide regulatory agencies and standards bodies, will highlight the main regulatory changes impacting the industry. This session is for any orthopedic professional who wants a forecast of regulatory pressures and seeks direction on how to shape change. Attendees will learn how FDA, European agencies and IMDRF are approaching harmonization and alignment of standards, regulations and guidance. OSMA Members will provide future trends and opportunities afforded via FDA’s National Evaluation System for Health Technology (NEST), facilitation of innovation through partnerships and global harmonization of regulatory submissions and facility assessments.
Our Quality Engineer, Madison Wheeler, discusses the characteristics of an efficient product development process for medical devices and how medical device product development should incorporate Quality, Regulatory, and Business needs in parallel.
Farm is an ISO 13485-certified and FDA-compliant product development consultancy with over 40 years of experience helping medical, life sciences, and consumer healthcare companies. It offers expertise in areas like user research, engineering, design, and regulatory compliance. Farm helps clients design devices that are safe, easy to use and effective by employing research, usability testing, and a process-driven development approach.
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...Covance
Getting a medical device to the patient takes more than good technology in today's environment. Compelling evidence and convincing value proposition matter. Competing priorities and differing stakeholder definitions of value are driving the need for creative, connected strategies to get the most from each step in the development process. And - as evidence is gathered - it should be used to inform and iterate regulatory, reimbursement and clinical post-market strategies.
Design Considerations to Maximize Medical Device Cloud ConnectivityGreenlight Guru
Medical device manufacturers are faced with a myriad of design decisions during product development. Several key decisions affecting market readiness must be addressed between bench-top prototypes and initiation of clinical trials. Among the most important are cloud connectivity considerations surrounding firmware, hardware, and use cases. The earlier cloud connectivity factors are identified, considered, and integrated into the design process, the more successful the resulting commercial roll-out in terms of cost, certification, and market acceptance.
• Key design factors medical device manufacturers should consider
• Advantages of considering connectivity early in the design process
• Practical use-case examples highlight more cost-effective clinical trials, wider market acceptance, and reduction in operational costs
This session took place live at the Greenlight Guru True Quality Virtual Summit, a three-day event for medical device professionals to learn to get their devices to market faster, stay ahead of regulatory changes, and use quality as their multiplier to grow their device business.
Additive Manufacturing Discussion Panel – Developing a Roadmap for Regulatory...April Bright
FDA published guidance on additive manufacturing technical considerations in late 2017, outlining the Agency’s long-awaited position on use of the technology for medical devices. At the time, FDA said that the 31-page document was considered “leapfrog” guidance, a term reserved for the Agency’s anticipation that its initial thoughts on an emerging technology will change over time. In short, more questions and answers have arisen — and will continue to do so as the technology is adopted. This FDA guidance is critical to the additive manufacturing narrative. However, standards and best practices surrounding the technology are being discussed globally on a daily basis. This discussion puts representatives from ASTM, FDA, SME and DePuy Synthes in one room, for one conversation, that will provide attendees with practical, actual guidance not only for current times, but also for what is on the horizon.
Implementing Agile in an FDA Regulated EnvironmentTechWell
Developing medical devices that are subject to FDA approval has traditionally followed the waterfall methodology, largely due to the structure of the regulations that govern development practices. But we know from myriad case studies in different industries that agile methodologies are far superior in providing the highest value to customers in the shortest time to market. Neal Herman shares how one developer of complex medical devices embraced agile software development practices and proved that it could not only develop software faster with higher quality but also meet all regulatory requirements. Convincing the internal quality management, systems engineering, and regulatory departments was difficult, but the software department was able to overcome these obstacles and fundamentally change the company’s philosophy on product development. Since 2012, software development productivity is up 100 percent, and quality is up 200 percent. Now, after seeing these gains from the software department, agile is being rolled out to all areas of R&D including hardware.
FDA Update: Inspections, Observations and Metrics - OMTEC 2017April Bright
This FDA-focused presentation offers a glimpse into trends behind three initiatives that orthopaedic device professionals need to fully understand: inspections, Case for Quality and 483 Observations. First, a high-level view of FDA inspections will discuss methodology and implementation. Second, FDA’s observations of non-compliance will be discussed, pointing out important historical trends. Finally, as the industry matures, professionals should expect changes to the breadth and depth of FDA’s focus. This is where Case for Quality and the Medical Device Metrics Initiative will be covered. FDA has placed an increased emphasis on data and metrics. Gain insight into ways to leverage data to improve, monitor and control processes that drive quality improvement.
These slides use concepts from my (Jeff Funk) course on Business Models at National University of Singapore to analyze the business model of SCIO’s molecular sensor. This pocket sensor uses infrared light to determine the molecular makeup of fruits, vegetables, drugs, and other organic materials. As a replacement for bulky spectrometers, it can be used by scientists, engineers, and consumers to determine the sugar content, nutritional value, and other aspects of organic materials. The slides describe the value proposition, method of value capture, customers, scope of activities, and method of strategic control for SCIO.
Accelerating Medical Device Development While Improving ComplianceAaron Joseph
The document discusses accelerating medical device development while improving compliance using lean and agile methods. It compares the traditional waterfall approach to a lean-agile approach through the story of two hypothetical product development teams. The lean-agile team prioritized learning and closing knowledge gaps early through testing, which allowed them to make more informed decisions later in development. The document provides examples of how agile software development practices can be adapted for medical device software while still meeting regulatory requirements.
Companies in multiple industries have found that lean and agile methods speed up their product development while simultaneously improving quality and cutting costs. In spite of these proven advantages, these methods have not been widely adopted in the highly regulated medical device industry. Regulations and standards do not prevent the adoption of lean and agile methods but many companies’ quality systems do. Understanding these barriers and how to modify quality system procedures is key to more efficient medical device development and improved compliance.
Almost 440 companies have completed the CONNECT Springboard accelerator program since 2005. More than 290 alumni have raised over $1.6 billion in capital. Nearly 20 percent of alumni have undergone liquidity events such as acquisitions or IPOs. As of 2016, over 250 Springboard graduates were still actively in business, with alumni companies creating more than 6,000 jobs. The accelerator focuses on tech, life sciences and consumer products companies, helping entrepreneurs refine their pitch and commercialization strategy.
FDA Inspections are Different from ISO Audits, So Don't Treat Them the Same -...April Bright
ISO audits and FDA inspections differ logistically, and should be approached in different manners. This presentation will explain the real-time differences between the two and, most importantly, give you strategies for preparation, behavioral tips for success during and after the assessments and recommendations for responding to the Registrar or FDA if deficiencies were discovered.
New European Medical Device Regulations: Keeping Your Orthopaedic and Spine ...April Bright
For years, notified bodies and industry experts have warned orthopaedic device companies to prepare for the forthcoming EU Medical Device Regulation (MDR). Though the regulation is expected to be officially published in the first half of 2017, a recent study shows that not only are companies not prepared, but regulatory and quality affairs professionals say that they have not studied the regulation closely.
The regulation includes new requirements for orthopaedic (and especially spine) companies that must be met in a timely manner to keep products on the market. Among the MDR changes are more stringent clinical evidence, identification of a “qualified person,” implementation of UDI and rigorous postmarket oversight.
Dr. Li covers highlights of the regulation and the provided transition period toward fulfillment of the new expectations. He explains the impact of device up-classification and the need for additional clinical data toward passing this new regulation successfully and toward fulfilling the postmarket reporting requirements accordingly.
This document discusses challenges for inventors and investors in raising capital for medical device development. It outlines four levels of innovation risk from lowest to highest - marginal, technological, therapeutic, and radical. Radical innovation involving new technology and new clinical uses poses the highest uncertainty. The document also compares perspectives of inventors, who focus on developing products, and investors, who seek returns. Their differing goals can cause challenges in collaborating on ventures. Additional hurdles include regulatory requirements and changing markets and technologies.
For those interested in Healthcare Fieldwork services - please take a look!Paul Morgan
M3 is a global market research firm that owns the largest online physician panel worldwide. They have over 2.5 million verified physicians across 70+ countries. M3 provides both quantitative and qualitative research services, including surveys, focus groups, and interviews. They are certified by ISO and CASRO to ensure high quality data collection processes and physician authentication.
Avoca Group was founded in 1999 and has since established several programs and initiatives focused on improving relationships and quality in clinical outsourcing. Some key events include Avoca launching the first comprehensive Relationship Management Program for a CRO in 2004, developing a system for measuring key relationship indicators in 2000, and CEO Patricia Leuchten being named one of the most inspiring individuals in the life sciences industry in 2012.
Prioritizing Documentation for MDR Transition PlanningGreenlight Guru
This session will discuss the one year delay of the MDR date of application as well as some strategies to employ during the MDR Transition. In addition, some approaches for determining documents to prioritize for the transition will be discussed.
This session took place live at the Greenlight Guru True Quality Virtual Summit, a three-day event for medical device professionals to learn to get their devices to market faster, stay ahead of regulatory changes, and use quality as their multiplier to grow their device business.
Why Design Validation is More Than Testing: How do we Validate our Validation?Greenlight Guru
This document summarizes a presentation titled "Why Design Validation is More Than Testing: How do we validate our validation?" given by Michael Drues, Ph.D. The presentation discusses how design validation involves more than just testing, and how companies can validate their validation strategies. It addresses questions like how to validate validation approaches, defend validations to regulatory agencies, and consider validation holistically rather than just required elements. The goal is to help attendees avoid costly validation mistakes and leverage validation strategically.
Understanding the Many Connotations of Risk in Medical Device Development and...Greenlight Guru
Risk mitigation in the medical device industry typically starts with a brainstorming session: the product development team randomly rattles off risks and writes them down.
This “cherry-picking” approach is a haphazard process because whether you spend an hour or a year, you can never be certain you have captured all the important risks.
Suffice it to say, this presentation is not the typical ISO 14971, QMS or Design Control approach which although commonly followed, all take a very limited view of risk and are simply not adequate for regulatory submissions.
Multiple examples of actual medical devices are used to demonstrate specifically:
-What are the three buckets of risk and how to apply them?
-What’s the difference between a risk mitigation strategy and a risk management plan?
-How to deemphasize or not draw attention to certain risks?
-What’s the relationship between risk mitigation and product liability?
-How to handle risks in off-label uses without creating product liability nightmares?
-How to factor regulatory risk into the equation
Watch the presentation here: https://www.greenlight.guru/webinar/many-connotations-risk-medical-device-development
Advanced Strategies and Tactics for Using the De Novo PathwayGreenlight Guru
There are many pathways medical device manufacturers may use to bring devices to market. Some, like the 510K and PMA, are commonly used while others like the de novo are not.
Although the de novo has not been frequently used in the past, recent changes in regulation including FDA's new “final” guidance that was releaed on Oct 30th, 2017, "De Novo Classification Process: Evaluation of Automatic Class III Designation" have made this pathway more attractive to many device manufacturers for the future.
While all areas of medical device technology may benefit, the de novo is particularly attractive in the areas of mobile medical apps, imaging and in vitro/companion diagnostics.
In many ways, the de novo is the simplest pathway to market, even simpler than the 510k!
Taken further, the de novo may be used as a competitive regulatory strategy not only to bring a device to market but also to create a barrier to entry to the competition!
Using the case study approach, you'll learn:
• What is the de novo pathway and when can I use it?
• What were the recent changes in regulation and how can they be used today?
• How do I design my de novo submission to maximize my probability of success?
• How can I use the de novo pathway to my competitive advantage?
Watch the presentation here: https://www.greenlight.guru/webinar/de-novo-pathway
ValGenesis Case Study With Scinopharm -Paperless Validation Software Solution ValGenesis
ValGenesis delivered a validated and qualified system in six weeks – the rapid implementation we needed. The system has been stable from the start, with little need for customer support calls, allowing us to focus on training and bringing on new users every week.”
— Steve Johnson, Director, Operations
Injectable Facility
ScinoPharm Taiwan, Ltd.
OSMA: Orthopedic Industry's Top Regulatory Challenges and OpportunitiesApril Bright
The Orthopaedic Surgical Manufacturers Association, a collective voice of orthopedic device companies that influences the decision of worldwide regulatory agencies and standards bodies, will highlight the main regulatory changes impacting the industry. This session is for any orthopedic professional who wants a forecast of regulatory pressures and seeks direction on how to shape change. Attendees will learn how FDA, European agencies and IMDRF are approaching harmonization and alignment of standards, regulations and guidance. OSMA Members will provide future trends and opportunities afforded via FDA’s National Evaluation System for Health Technology (NEST), facilitation of innovation through partnerships and global harmonization of regulatory submissions and facility assessments.
Our Quality Engineer, Madison Wheeler, discusses the characteristics of an efficient product development process for medical devices and how medical device product development should incorporate Quality, Regulatory, and Business needs in parallel.
Farm is an ISO 13485-certified and FDA-compliant product development consultancy with over 40 years of experience helping medical, life sciences, and consumer healthcare companies. It offers expertise in areas like user research, engineering, design, and regulatory compliance. Farm helps clients design devices that are safe, easy to use and effective by employing research, usability testing, and a process-driven development approach.
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...Covance
Getting a medical device to the patient takes more than good technology in today's environment. Compelling evidence and convincing value proposition matter. Competing priorities and differing stakeholder definitions of value are driving the need for creative, connected strategies to get the most from each step in the development process. And - as evidence is gathered - it should be used to inform and iterate regulatory, reimbursement and clinical post-market strategies.
Design Considerations to Maximize Medical Device Cloud ConnectivityGreenlight Guru
Medical device manufacturers are faced with a myriad of design decisions during product development. Several key decisions affecting market readiness must be addressed between bench-top prototypes and initiation of clinical trials. Among the most important are cloud connectivity considerations surrounding firmware, hardware, and use cases. The earlier cloud connectivity factors are identified, considered, and integrated into the design process, the more successful the resulting commercial roll-out in terms of cost, certification, and market acceptance.
• Key design factors medical device manufacturers should consider
• Advantages of considering connectivity early in the design process
• Practical use-case examples highlight more cost-effective clinical trials, wider market acceptance, and reduction in operational costs
This session took place live at the Greenlight Guru True Quality Virtual Summit, a three-day event for medical device professionals to learn to get their devices to market faster, stay ahead of regulatory changes, and use quality as their multiplier to grow their device business.
Additive Manufacturing Discussion Panel – Developing a Roadmap for Regulatory...April Bright
FDA published guidance on additive manufacturing technical considerations in late 2017, outlining the Agency’s long-awaited position on use of the technology for medical devices. At the time, FDA said that the 31-page document was considered “leapfrog” guidance, a term reserved for the Agency’s anticipation that its initial thoughts on an emerging technology will change over time. In short, more questions and answers have arisen — and will continue to do so as the technology is adopted. This FDA guidance is critical to the additive manufacturing narrative. However, standards and best practices surrounding the technology are being discussed globally on a daily basis. This discussion puts representatives from ASTM, FDA, SME and DePuy Synthes in one room, for one conversation, that will provide attendees with practical, actual guidance not only for current times, but also for what is on the horizon.
Implementing Agile in an FDA Regulated EnvironmentTechWell
Developing medical devices that are subject to FDA approval has traditionally followed the waterfall methodology, largely due to the structure of the regulations that govern development practices. But we know from myriad case studies in different industries that agile methodologies are far superior in providing the highest value to customers in the shortest time to market. Neal Herman shares how one developer of complex medical devices embraced agile software development practices and proved that it could not only develop software faster with higher quality but also meet all regulatory requirements. Convincing the internal quality management, systems engineering, and regulatory departments was difficult, but the software department was able to overcome these obstacles and fundamentally change the company’s philosophy on product development. Since 2012, software development productivity is up 100 percent, and quality is up 200 percent. Now, after seeing these gains from the software department, agile is being rolled out to all areas of R&D including hardware.
FDA Update: Inspections, Observations and Metrics - OMTEC 2017April Bright
This FDA-focused presentation offers a glimpse into trends behind three initiatives that orthopaedic device professionals need to fully understand: inspections, Case for Quality and 483 Observations. First, a high-level view of FDA inspections will discuss methodology and implementation. Second, FDA’s observations of non-compliance will be discussed, pointing out important historical trends. Finally, as the industry matures, professionals should expect changes to the breadth and depth of FDA’s focus. This is where Case for Quality and the Medical Device Metrics Initiative will be covered. FDA has placed an increased emphasis on data and metrics. Gain insight into ways to leverage data to improve, monitor and control processes that drive quality improvement.
These slides use concepts from my (Jeff Funk) course on Business Models at National University of Singapore to analyze the business model of SCIO’s molecular sensor. This pocket sensor uses infrared light to determine the molecular makeup of fruits, vegetables, drugs, and other organic materials. As a replacement for bulky spectrometers, it can be used by scientists, engineers, and consumers to determine the sugar content, nutritional value, and other aspects of organic materials. The slides describe the value proposition, method of value capture, customers, scope of activities, and method of strategic control for SCIO.
Accelerating Medical Device Development While Improving ComplianceAaron Joseph
The document discusses accelerating medical device development while improving compliance using lean and agile methods. It compares the traditional waterfall approach to a lean-agile approach through the story of two hypothetical product development teams. The lean-agile team prioritized learning and closing knowledge gaps early through testing, which allowed them to make more informed decisions later in development. The document provides examples of how agile software development practices can be adapted for medical device software while still meeting regulatory requirements.
Companies in multiple industries have found that lean and agile methods speed up their product development while simultaneously improving quality and cutting costs. In spite of these proven advantages, these methods have not been widely adopted in the highly regulated medical device industry. Regulations and standards do not prevent the adoption of lean and agile methods but many companies’ quality systems do. Understanding these barriers and how to modify quality system procedures is key to more efficient medical device development and improved compliance.
Almost 440 companies have completed the CONNECT Springboard accelerator program since 2005. More than 290 alumni have raised over $1.6 billion in capital. Nearly 20 percent of alumni have undergone liquidity events such as acquisitions or IPOs. As of 2016, over 250 Springboard graduates were still actively in business, with alumni companies creating more than 6,000 jobs. The accelerator focuses on tech, life sciences and consumer products companies, helping entrepreneurs refine their pitch and commercialization strategy.
FDA Inspections are Different from ISO Audits, So Don't Treat Them the Same -...April Bright
ISO audits and FDA inspections differ logistically, and should be approached in different manners. This presentation will explain the real-time differences between the two and, most importantly, give you strategies for preparation, behavioral tips for success during and after the assessments and recommendations for responding to the Registrar or FDA if deficiencies were discovered.
New European Medical Device Regulations: Keeping Your Orthopaedic and Spine ...April Bright
For years, notified bodies and industry experts have warned orthopaedic device companies to prepare for the forthcoming EU Medical Device Regulation (MDR). Though the regulation is expected to be officially published in the first half of 2017, a recent study shows that not only are companies not prepared, but regulatory and quality affairs professionals say that they have not studied the regulation closely.
The regulation includes new requirements for orthopaedic (and especially spine) companies that must be met in a timely manner to keep products on the market. Among the MDR changes are more stringent clinical evidence, identification of a “qualified person,” implementation of UDI and rigorous postmarket oversight.
Dr. Li covers highlights of the regulation and the provided transition period toward fulfillment of the new expectations. He explains the impact of device up-classification and the need for additional clinical data toward passing this new regulation successfully and toward fulfilling the postmarket reporting requirements accordingly.
This document discusses challenges for inventors and investors in raising capital for medical device development. It outlines four levels of innovation risk from lowest to highest - marginal, technological, therapeutic, and radical. Radical innovation involving new technology and new clinical uses poses the highest uncertainty. The document also compares perspectives of inventors, who focus on developing products, and investors, who seek returns. Their differing goals can cause challenges in collaborating on ventures. Additional hurdles include regulatory requirements and changing markets and technologies.
For those interested in Healthcare Fieldwork services - please take a look!Paul Morgan
M3 is a global market research firm that owns the largest online physician panel worldwide. They have over 2.5 million verified physicians across 70+ countries. M3 provides both quantitative and qualitative research services, including surveys, focus groups, and interviews. They are certified by ISO and CASRO to ensure high quality data collection processes and physician authentication.
Avoca Group was founded in 1999 and has since established several programs and initiatives focused on improving relationships and quality in clinical outsourcing. Some key events include Avoca launching the first comprehensive Relationship Management Program for a CRO in 2004, developing a system for measuring key relationship indicators in 2000, and CEO Patricia Leuchten being named one of the most inspiring individuals in the life sciences industry in 2012.
Prioritizing Documentation for MDR Transition PlanningGreenlight Guru
This session will discuss the one year delay of the MDR date of application as well as some strategies to employ during the MDR Transition. In addition, some approaches for determining documents to prioritize for the transition will be discussed.
This session took place live at the Greenlight Guru True Quality Virtual Summit, a three-day event for medical device professionals to learn to get their devices to market faster, stay ahead of regulatory changes, and use quality as their multiplier to grow their device business.
Why Design Validation is More Than Testing: How do we Validate our Validation?Greenlight Guru
This document summarizes a presentation titled "Why Design Validation is More Than Testing: How do we validate our validation?" given by Michael Drues, Ph.D. The presentation discusses how design validation involves more than just testing, and how companies can validate their validation strategies. It addresses questions like how to validate validation approaches, defend validations to regulatory agencies, and consider validation holistically rather than just required elements. The goal is to help attendees avoid costly validation mistakes and leverage validation strategically.
Understanding the Many Connotations of Risk in Medical Device Development and...Greenlight Guru
Risk mitigation in the medical device industry typically starts with a brainstorming session: the product development team randomly rattles off risks and writes them down.
This “cherry-picking” approach is a haphazard process because whether you spend an hour or a year, you can never be certain you have captured all the important risks.
Suffice it to say, this presentation is not the typical ISO 14971, QMS or Design Control approach which although commonly followed, all take a very limited view of risk and are simply not adequate for regulatory submissions.
Multiple examples of actual medical devices are used to demonstrate specifically:
-What are the three buckets of risk and how to apply them?
-What’s the difference between a risk mitigation strategy and a risk management plan?
-How to deemphasize or not draw attention to certain risks?
-What’s the relationship between risk mitigation and product liability?
-How to handle risks in off-label uses without creating product liability nightmares?
-How to factor regulatory risk into the equation
Watch the presentation here: https://www.greenlight.guru/webinar/many-connotations-risk-medical-device-development
Advanced Strategies and Tactics for Using the De Novo PathwayGreenlight Guru
There are many pathways medical device manufacturers may use to bring devices to market. Some, like the 510K and PMA, are commonly used while others like the de novo are not.
Although the de novo has not been frequently used in the past, recent changes in regulation including FDA's new “final” guidance that was releaed on Oct 30th, 2017, "De Novo Classification Process: Evaluation of Automatic Class III Designation" have made this pathway more attractive to many device manufacturers for the future.
While all areas of medical device technology may benefit, the de novo is particularly attractive in the areas of mobile medical apps, imaging and in vitro/companion diagnostics.
In many ways, the de novo is the simplest pathway to market, even simpler than the 510k!
Taken further, the de novo may be used as a competitive regulatory strategy not only to bring a device to market but also to create a barrier to entry to the competition!
Using the case study approach, you'll learn:
• What is the de novo pathway and when can I use it?
• What were the recent changes in regulation and how can they be used today?
• How do I design my de novo submission to maximize my probability of success?
• How can I use the de novo pathway to my competitive advantage?
Watch the presentation here: https://www.greenlight.guru/webinar/de-novo-pathway
Designing an International Regulatory Strategy: Why do so many get it wrong?Greenlight Guru
What is Regulatory Strategy?
Why is Regulatory Strategy important?
What is International Regulatory Strategy?
Why is International Regulatory Strategy important?
How early in the product development lifecycle should we consider international regulatory strategy?
What’s the relationship between International Regulatory Strategy and International Reimbursement Strategy?
This presentation originally aired during the 2022 Global MedTech Regulatory Trends Virtual Summit.
General Wellness Devices & Wearables: Regulatory Options you Need to Know Greenlight Guru
Most medical device companies take their products to FDA prior to marketing. But is there a way to legally market a medical device without taking it to FDA first?
Maybe! The “general wellness exemption” provides a way to legally market certain medical devices without FDA clearance or approval.
When used effectively, the general wellness exemption offers significant advantages in to market sooner. But if not used properly, the wellness exemption can significantly increase the regulatory risk of punitive action.
Using the case study approach, you will learn:
-What is the general wellness exemption and how can we use it to get to market faster?
-What are the regulatory challenges of wearable medical devices?
-What can I say in my label under the general wellness exemption?
-What does risk mean in the context of a wellness device?
-Why is usability for wellness devices more important than traditional medical devices?
-How can I use a wellness device as a label expansion later?
-Do other countries recognize wellness devices?
Learn more here: https://www.greenlight.guru/webinar/general-wellness-devices
Guidance to physicians providing expert services in the medicolegal arena, e.g. workers' compensation and disability systems, of how to perform this work in a virtual environment.
Emerging Participatory Research Methods for Digital Health CommunicationsAlex Bornkessel
This presentation was given as a part of the Health Communication Capacity Collaborative's (HC3) Health Communication Innovation Webinar Series. Many of the research methods highlighted however can also apply beyond the realm of just health communication and into other areas and across a diverse set of population groups.
Recording is located at: http://www.healthcommcapacity.org/blog/hc3-innovation-webinar-2-research-methodologies
The Skynet Effect: How HR Can Best Utilize AIAggregage
https://www.humanresourcestoday.com/frs/24235077/the-skynet-effect--how-hr-can-best-utilize-ai/email
AI this, AI that. No matter where you go, AI seems to be all anyone in HR wants to talk about. It might be a little irritating, but it’s inescapable for a good reason. Artificial intelligence, specifically ChatGPT, is now an important topic of conversation for all industries.
Like anything new, there are plenty of questions and misconceptions about how AI will change workplace dynamics. But modern AI isn’t Skynet trying to take over the world, and instead of fearing it, your organization can embrace the efficiencies and positive impacts that it offers.
In this webinar, Iveta Brigis, Vice President, People Operations, and Wesley Pasfield, Head of Data Science will address:
• How to better understand AI, specifically ChatGPT
• Use cases for AI in the employer space
• Considerations and questions to ask when evaluating an AI vendor
• Concerns about AI affecting HR employment availability
• How AI can enhance HR jobs when used responsibly
English Resources Writing Junior Cycle For Teachers (Lisa Olive
The document discusses different perspectives on the effectiveness of the education system. Dwyer, Holt and Adams have differing views, with Dwyer being more critical of the system. A good education balances academic learning with developing social/life skills to prepare students for their future. While school provides structure, it also places unnecessary stress on students and could be improved.
Digital health: How technology and social media is changing our practiseKartik Modha
Presentation given at Pulse Live 2013 in Birmingham by Dr Kartik Modha. Chairman and CEO of myHealthSpecialist.com, Founder and Chair of Tiko's GP Group.
This document provides information about the HST.921 course on Information Technology in the Healthcare System of the Future offered at Harvard and MIT in spring 2009. The course aims to empower students to critically analyze current or future healthcare problems and develop novel IT solutions. It includes weekly lectures, tutorials/labs, and a group project. Students work in multidisciplinary teams on design, business, marketing, or clinical trial tracks. Past projects addressed topics like social media, serious games, telehealth, and disease management technologies. The course is open to students from various Harvard and MIT programs for credit.
Sample Of Evaluation Essay - Zbuild.Web.Fc2.ComMary Burg
The RAYBEN Mentoring Program at Huntsville, AL aims to inspire career development and facilitate academic growth for mentees through exchanging personal experiences and guidance from mentors, while also providing mentors with networking opportunities, feedback, and scholarship. The program seeks to enrich both mentors and mentees through mentorship, with immediate benefits including expanding knowledge, skills, and personal growth for mentees and networking, feedback, and opportunities for mentors.
Careers Information JjjjjjjjjjjjjjjjjjPrince GeorgTawnaDelatorrejs
Careers Information
Jjjjjjjjjjjjjjjjjj
Prince George Community College
INT 1010
Professor yyyyyyyy
Date: February 28, 2021
CYBER SECURITY 7
Table of Content
Table of Contents…………………………………………………………………………...1
Abstract……………………………………………………………………………………..2
Description of Careers………………………………………………………………………3
Description of Careers………………………………………………………………………4
Emerging Technologies Used to Improve Production or Workflow……………………….5
Ethical Issues in the Industries……………………………………………………………..6
Conclusion………………………………………………………………………………….7
References………………………………………………………………………………….8
Abstract
Every career is unique; hence, those who want to join them require specific academic qualifications and accreditations. Subsequently, the roles and responsibilities that professionals are tasked with differ significantly. This essay looks at two essential professions; cybersecurity specialists and pharmacists. It analyzes significant factors about the careers, including what the jobs entail and the qualification needed to practice in the two fields. It also scrutinizes the emerging technological tools used to enhance the professionals' workflow and the ethical issues encountered in the industries.
Description of the Careers
Cybersecurity specialists are professionals tasked with overseeing everyday operations in the technological sector to ensure the optimal technical and data systems' optimal function. Their duties include:
· Detecting and preventing any security risks that may emerge during operations
· Avert any possible susceptibilities threatening the system
· Undertaking investigative research and test the available technological appliances to decipher any potential threats and mitigate them.
· They also monitor day-to-day operations to resolve security and data-related issues.
· Install necessary security measures and protocols (Cybersecurity Career Paths and Progression, 2019).
· Coach staff members on security measures and investigate ways of eradicating the risks with which technological systems grapple.
Individuals interested in the career have to successfully go through a degree program in computer science or a similar educational path. (Cybersecurity Career Paths and Progression, 2019). They should also have advanced IT skills and apply critical thinking skills while carrying out their tasks. The professionals' average salary is between $60,000 and $110 000, depending on their level of experience and positions in organizations. The average wages for cybersecurity specialists also differ in different states. In Maryland, the professional's net pay is $102, 000 while in Virginia, itis$99,000 https://niccs.cisa.gov/sites/default/files/documents/pdf/cybersecurity. On the other hand, those in Washington D. C receive a higher income of up to $108,500.
A pharmacist is a medical professional tasked with preparing prescribed medicines and disseminating useful information about using them correctly. They identify a ...
The document describes an off-grid tech solution called Eye-Dentify that aims to make patient tracking and data collection more accurate and efficient during medical outreach campaigns to optimize patient care. It consists of (1) a $5-12 patient bracelet that identifies and tracks patients, storing and transferring their data between stations and (2) a digitized patient record accessed on a portable device. The solution aims to address inefficiencies in paper-based systems like lost records and time spent re-collecting data. It seeks funding and partnerships to pilot the solution and further test its value proposition and business model.
Social media and online strategy is important for doctors who want to help patients, make the most of their careers, and protect their reputations. Physicians and other healthcare leaders can safely and effectively engage online within social media and other digital platforms.
This document outlines the responsibilities and skills required for a case management supervisor. It discusses promoting high quality case management through professional development programs, practice reviews, ensuring adherence to organizational policies and relevant standards, and researching current trends to continually improve practices. A supervisor must have strong skills in roles like mentoring, facilitating feedback, team management, and data analysis. They must also have thorough knowledge of case management theories, models of supervision, applicable legislation, and their own values when leading a team.
The document discusses using user personas to guide the design of a healthcare portal. It describes conducting research including interviews with 43 users from 4 countries to develop 9 personas representing the goals and needs of key user groups such as radiologists, administrators, and patients. The personas are used to ensure the portal design meets user needs and supports critical tasks.
[Case Study] Physician, Know Thy User: Using Personas to Target Content and U...Scott Abel
Presented by Joe Sokohl at Documentation and Training Life Sciences, June 23-26, 208 in Indianapolis.
Ever have a project fail? You met with your project team, you talked with the customer, you reviewed technical requirements. But did you talk to your users? Just as one diagnosis doesn’t fit all patients, one application’s approach doesn’t work for all users. Know who accesses your information and uses your applications. Only then choose your features. Using a case study of a multinational project covering four countries, 10 business units, and tens of thousands of content elements, we’ll explore personas, scenarios, and other user-centered techniques. We’ll look at identifying users as well as segregating content according to users and regulatory needs.
What was involved in this cases study?
First we analyzed the 10 business units and their approaches and definitions of business goals. Next we analyzed industry standards for medical devices and their usage.
But that wasn’t enough. We interviewed 40 people in 4 countries, and created an information architecture prototype. We then tested this prototype in hospitals, doctors’ offices, and on site where medical devices were in use.
Based on this contextual inquiry, we refined the architecture and our understanding of the users. Decisions were then made on what type of content would be both appropriate and legal for each user and in each country.
Only with a solid understanding of the users and their goals could we define a flexible, extensible, and usable information and content architecture.
The 10 most impactful healthcare solution providers of 2019Mirror Review
In the magazine, “The 10 Most Impactful Healthcare Solution
Providers of 2019,” we have featured the companies which are helping
the industry to become smarter and more efficient by providing their
out-of-the-box solutions and services. These companies include,
Camomile Healthcare Ventures, Canadian Plasma Resources,
Conversa Health, and Medbelle. We have also explored how these companies are benefiting the various parts of the pipeline.
https://www.mirrorreview.com
https://blog.mirrorreview.com
Similar to Bridging User Needs & Design Requirements: Answers are Only as Good as the Questions We Ask! (20)
The Compliance Concern: Challenges and Roadblocks for Ensuring Compliance in ...Greenlight Guru
The medical device industry is doubling down on compliance readiness. This is a significant shift from last year when we saw accelerating product development as the main goal. Ensuring compliance is a requirement for continued success, and most importantly, patient safety. The panelists will discuss the challenges device companies face as they manage compliance throughout the product lifecycle.
How Electronic Data Capture Is Transforming the MedTech IndustryGreenlight Guru
Clinical research is crucial to the life science industry. But did you know that medical device companies require a different approach? In this discussion, our panelists will talk about the challenges of clinical operations for MedTech, the benefits of leveraging MedTech-specific Electronic Data Capture (EDC) systems, the pitfalls of using outdated clinical data collection methods, such as paper, and much more!
The ROI of Shifting Mindset From Compliance to QualityGreenlight Guru
Many MedTech companies focus on compliance without considering the importance of quality. In this session, panelists will dive into the differences between compliance vs. quality, the benefits of shifting mindset towards quality, and tips on how to start embedding quality into your organization.
Leveraging Modern Software Technologies: MedTech’s Best Kept SecretGreenlight Guru
There are several moving pieces that influence a medical device company’s time-to-market and continued success. An often overlooked (yet critical) one is the tools used to manage the product lifecycle. Are your tools working for you or slowing down your success? In this session, panelists will discuss trends from the 2023 survey results, common challenges with disjointed software solutions, the impact of modernizing, and the power of a modern QMS.
Behind the Stats: Expectations vs. Reality of Bringing a Device to MarketGreenlight Guru
Learn about what’s currently impacting the broader medical device industry. Our panelists will kick off the week by going over all the trends, statistics, and themes uncovered from the 2023 MedTech Industry Benchmark Survey. The session will uncover major shifts in industry goals, the use of modern Medtech software tools, major gaps in product lifecycle processes, and more. Discover how you can apply these findings as you make decisions within your organization in 2023 and beyond.
Common Misconceptions on Medical Device Risk & Design ControlsGreenlight Guru
Learn about common misconceptions on medical device risk and design controls.
This presentation originally aired during the 2022 Future of QMS Requirements Virtual Summit.
QMSR Harmonization: The Future of FDA's Quality Management System RegulationGreenlight Guru
Learn about the future of FDA's Quality Management System regulation.
This presentation originally aired during the 2022 Future of QMS Requirements Virtual Summit.
Today we will discuss why a QMS is the backbone of Regulatory through the lens of ISO 13845. The presentation will cover the importance of starting a QMS early and ahead of a regulatory strategy.
This presentation originally aired during the 2022 Future of QMS Requirements Virtual Summit.
Modernizing your QMS to keep up with the Modern Age of RequirementsGreenlight Guru
Learn about the importance of a modern QMS to keep up with changing requirements in the MedTech industry.
This presentation originally aired during the 2022 Future of QMS Requirements Virtual Summit.
In this session we will learn about the Why, the What, the Who, and the How for Medical Device Reporting to FDA through eMDR Submissions.
This presentation originally aired during the 2022 Future of QMS Requirements Virtual Summit.
Moving up to the State of the Art in Risk ManagementGreenlight Guru
During this presentation we will explore where Medical Device Risk Management Systems are today. We will look at the quickly upcoming deadlines for implementing the ISO 14971:2019 3rd Edition, and EN ISO 14971:2019/A11:2021 standards. We will also mention the potential next (4th) edition of ISO 14971, and how the industry may influence the next edition.
This presentation originally aired during the 2022 Future of QMS Requirements Virtual Summit.
While ISO 13485 is written in black and white, the alignment between the standard's requirements and expectations is not always clear - especially in regards to SaMD (software as a medical device). This session will discuss aligning ISO 13485 with best practices for SaMD, and how we can expect the shift of the industry to impact the anchor standard of the medical device industry.
This presentation originally aired during the 2022 Future of QMS Requirements Virtual Summit.
Computer Software Assurance (CSA): Understanding the FDA’s New Draft GuidanceGreenlight Guru
Understand the FDA's new draft guidance on Computer Software Assurance (CSA).
This presentation originally aired during the 2022 Future of QMS Requirements Virtual Summit.
Making Headway Despite the Turbulence: Regulatory Requirements, Quality, and ...Greenlight Guru
The European Union’s In Vitro Diagnostic Medical Devices Regulation, or IVDR, became effective May 26, 2022. In this session, you’ll get a glimpse of what’s changed since implementation day, the latest guidance available, and ways to keep your IVDD to IVDR transition moving forward.
This presentation originally aired during the 2022 Global MedTech Regulatory Trends Virtual Summit.
Reducing Friction Between Companies and Regulatory BodiesGreenlight Guru
We are operating in a complex environment, which is still undergoing changes. A lack of regulatory/quality management resources can be seen on both notified bodies and the industry. To overcome these hurdles, close collaboration and communication between companies and the notified body is necessary.
This presentation originally aired during the 2022 Global MedTech Regulatory Trends Virtual Summit.
Latin American Regulations - What you Don't KnowGreenlight Guru
Central and South America are emerging as hot new Medical Device markets. These two subject matter experts in the area break down everything from regulatory advantages and ethical dilemmas.
This presentation originally aired during the 2022 Global MedTech Regulatory Trends Virtual Summit.
Insights on the MedTech Regulatory and Clinical Environment in IsraelGreenlight Guru
This document provides an overview of the medical device regulatory and clinical environment in Israel. It discusses IQVIA's MedTech Regulatory Solutions group and their expertise in guiding clients through the medical device development and regulatory process. It then provides context on Israel's healthcare system, describing it as technologically advanced with a national health insurance program. The document outlines Israel's medical device law and registration process, noting requirements around clinical data, labeling, and changes. It also describes benefits of conducting clinical trials in Israel such as its skilled workforce and diverse population.
The Global Guide to Human Factors and Usability Engineering RegulationsGreenlight Guru
The regulatory landscape related to human factors and usability engineering has continued to evolve since FDA issued its draft guidance for human factors over ten years ago. In fact, the international standard for usability engineering, IEC 62366-1: 2015 was amended as recently as 2020. The good news is that the pathway to a successful regulatory strategy, in terms of human factors and usability engineering, has never been more clear. The regulators have spoken, by way of guidance and standards documents, all that is left to do is to make sense of it all as it relates to your specific device or product.
This presentation originally aired during the 2022 Global MedTech Regulatory Trends Virtual Summit.
Join industry expert, Danny Kroo, key takeaways from the session include: 1. What is MDSAP and when should you consider it? 2. How to prepare for an MDSAP certification audit 3. What are common nonconformities issued by auditing organizations
This presentation originally aired during the 2022 Global MedTech Regulatory Trends Virtual Summit.
QMSR Harmonization - The Good the Bad and the UglyGreenlight Guru
Learn about the proposed QMSR rule, intended benefits of MDSAP for the regulatory authorities, benefits for the manufacturer, and similarities between ISO 13485 and FDA Regulations, and more!
This presentation originally aired during the 2022 Global MedTech Regulatory Trends Virtual Summit.
The 10 Most Influential Leaders Guiding Corporate Evolution, 2024.pdfthesiliconleaders
In the recent edition, The 10 Most Influential Leaders Guiding Corporate Evolution, 2024, The Silicon Leaders magazine gladly features Dejan Štancer, President of the Global Chamber of Business Leaders (GCBL), along with other leaders.
SATTA MATKA SATTA FAST RESULT KALYAN TOP MATKA RESULT KALYAN SATTA MATKA FAST RESULT MILAN RATAN RAJDHANI MAIN BAZAR MATKA FAST TIPS RESULT MATKA CHART JODI CHART PANEL CHART FREE FIX GAME SATTAMATKA ! MATKA MOBI SATTA 143 spboss.in TOP NO1 RESULT FULL RATE MATKA ONLINE GAME PLAY BY APP SPBOSS
How to Implement a Strategy: Transform Your Strategy with BSC Designer's Comp...Aleksey Savkin
The Strategy Implementation System offers a structured approach to translating stakeholder needs into actionable strategies using high-level and low-level scorecards. It involves stakeholder analysis, strategy decomposition, adoption of strategic frameworks like Balanced Scorecard or OKR, and alignment of goals, initiatives, and KPIs.
Key Components:
- Stakeholder Analysis
- Strategy Decomposition
- Adoption of Business Frameworks
- Goal Setting
- Initiatives and Action Plans
- KPIs and Performance Metrics
- Learning and Adaptation
- Alignment and Cascading of Scorecards
Benefits:
- Systematic strategy formulation and execution.
- Framework flexibility and automation.
- Enhanced alignment and strategic focus across the organization.
Unveiling the Dynamic Personalities, Key Dates, and Horoscope Insights: Gemin...my Pandit
Explore the fascinating world of the Gemini Zodiac Sign. Discover the unique personality traits, key dates, and horoscope insights of Gemini individuals. Learn how their sociable, communicative nature and boundless curiosity make them the dynamic explorers of the zodiac. Dive into the duality of the Gemini sign and understand their intellectual and adventurous spirit.
Digital Marketing with a Focus on Sustainabilitysssourabhsharma
Digital Marketing best practices including influencer marketing, content creators, and omnichannel marketing for Sustainable Brands at the Sustainable Cosmetics Summit 2024 in New York
Easily Verify Compliance and Security with Binance KYCAny kyc Account
Use our simple KYC verification guide to make sure your Binance account is safe and compliant. Discover the fundamentals, appreciate the significance of KYC, and trade on one of the biggest cryptocurrency exchanges with confidence.
Top mailing list providers in the USA.pptxJeremyPeirce1
Discover the top mailing list providers in the USA, offering targeted lists, segmentation, and analytics to optimize your marketing campaigns and drive engagement.
3 Simple Steps To Buy Verified Payoneer Account In 2024SEOSMMEARTH
Buy Verified Payoneer Account: Quick and Secure Way to Receive Payments
Buy Verified Payoneer Account With 100% secure documents, [ USA, UK, CA ]. Are you looking for a reliable and safe way to receive payments online? Then you need buy verified Payoneer account ! Payoneer is a global payment platform that allows businesses and individuals to send and receive money in over 200 countries.
If You Want To More Information just Contact Now:
Skype: SEOSMMEARTH
Telegram: @seosmmearth
Gmail: seosmmearth@gmail.com
Structural Design Process: Step-by-Step Guide for BuildingsChandresh Chudasama
The structural design process is explained: Follow our step-by-step guide to understand building design intricacies and ensure structural integrity. Learn how to build wonderful buildings with the help of our detailed information. Learn how to create structures with durability and reliability and also gain insights on ways of managing structures.
The APCO Geopolitical Radar - Q3 2024 The Global Operating Environment for Bu...APCO
The Radar reflects input from APCO’s teams located around the world. It distils a host of interconnected events and trends into insights to inform operational and strategic decisions. Issues covered in this edition include:
How MJ Global Leads the Packaging Industry.pdfMJ Global
MJ Global's success in staying ahead of the curve in the packaging industry is a testament to its dedication to innovation, sustainability, and customer-centricity. By embracing technological advancements, leading in eco-friendly solutions, collaborating with industry leaders, and adapting to evolving consumer preferences, MJ Global continues to set new standards in the packaging sector.